p3 health partners (p3) is a patient-centered, physician-led and population health-focused healthcare company. founded and led by physicians, sherif abdou, and amir bacchus, p3 is a team of doctors, clinicians and support service professionals with a shared passion and purpose for improving the way patient care is delivered. we are on a mission to change the way healthcare is delivered. we believe that together as physicians, we can heal the system, restore purpose and meaning in day-to-day operations, and infuse care and health back into healthcare.
Company profile
Ticker
PIII
Exchange
Website
CEO
Sherif Abdou
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Foresight Acquisition Corp.
SEC CIK
Corporate docs
Subsidiaries
P3 Health Group, LLC • P3 Health Partners, LLC • P3 Health Partners-California, LLC • P3 Health Partners-Nevada, LLC • P3 Health Partners-Oregon LLC ...
IRS number
852992794
PIII stock data
Latest filings (excl ownership)
NT 10-K
Notice of late annual filing
12 Mar 24
8-K
Amendments to Articles of Incorporation or Bylaws
12 Mar 24
8-K
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024
9 Jan 24
424B3
Prospectus supplement
21 Nov 23
424B3
Prospectus supplement
21 Nov 23
EFFECT
Notice of effectiveness
21 Nov 23
EFFECT
Notice of effectiveness
21 Nov 23
EFFECT
Notice of effectiveness
21 Nov 23
CORRESP
Correspondence with SEC
16 Nov 23
UPLOAD
Letter from SEC
16 Nov 23
Latest ownership filings
SC 13G/A
AMERIPRISE FINANCIAL INC
27 Feb 24
SC 13G/A
AMERIPRISE FINANCIAL INC
14 Feb 24
SC 13G/A
VANGUARD GROUP INC
13 Feb 24
SC 13G/A
LMR Partners LLP
12 Feb 24
4
Thomas Edmunds Price
25 Jan 24
4
MARY A TOLAN
25 Jan 24
4
Mark Thierer
25 Jan 24
4
GREGORY D WASSON
25 Jan 24
4
Lawrence B. Leisure
25 Jan 24
4
Gregory N. Kazarian
25 Jan 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 57.44 mm | 57.44 mm | 57.44 mm | 57.44 mm | 57.44 mm | 57.44 mm |
Cash burn (monthly) | 2.69 mm | (no burn) | 12.29 mm | 54.41 mm | 2.53 mm | 7.68 mm |
Cash used (since last report) | 16.01 mm | n/a | 73.26 mm | 324.27 mm | 15.07 mm | 45.74 mm |
Cash remaining | 41.43 mm | n/a | -15.82 mm | -266.83 mm | 42.37 mm | 11.70 mm |
Runway (months of cash) | 15.4 | n/a | -1.3 | -4.9 | 16.8 | 1.5 |
Institutional ownership, Q2 2023
13F holders | Current |
---|---|
Total holders | 71 |
Opened positions | 55 |
Closed positions | 22 |
Increased positions | 7 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 83.81 bn |
Total shares | 227.23 mm |
Total puts | 0.00 |
Total calls | 3.48 mm |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Chicago Pacific Founders UGP | 110.42 mm | $121.46 mm |
Hudson Vegas Investment SPV | 43.97 mm | $416.88 mm |
Leavitt Equity Partners II | 24.72 mm | $24.72 mm |
Sherif Abdou | 7.91 mm | $39.62 mm |
Foresight Sponsor | 7.75 mm | $54.59 mm |
FMR | 6.89 mm | $20.59 bn |
Vanguard | 5.47 mm | $16.37 bn |
JHG Janus Henderson | 4.98 mm | $14.90 bn |
Amir Bacchus | 4.20 mm | $4.20 mm |
AMP Ameriprise Financial | 2.61 mm | $7.80 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Jan 24 | Amir Bacchus | Class A Common Stock | Other | Acquire J | No | No | 0 | 287,118 | 0.00 | 2,005,193 |
9 Jan 24 | Sherif Abdou | Class A Common Stock | Other | Acquire J | No | No | 0 | 483,868 | 0.00 | 1,608,225 |
31 Dec 23 | Sherif Abdou | Class A Common Stock | Payment of exercise | Dispose F | No | No | 1.41 | 483,868 | 682.25 k | 1,124,357 |
31 Dec 23 | Amir Bacchus | Class A Common Stock | Payment of exercise | Dispose F | No | No | 1.41 | 287,118 | 404.84 k | 1,718,075 |
23 Oct 23 | Jeffrey G Park | Class A Common Stock | Grant | Acquire A | No | No | 0 | 216,561 | 0.00 | 216,561 |
News
Earnings Scheduled For March 28, 2024
28 Mar 24
P3 Health Partners's Earnings: A Preview
27 Mar 24
12 Health Care Stocks Moving In Friday's Intraday Session
15 Mar 24
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4.5
14 Mar 24
12 Health Care Stocks Moving In Wednesday's Intraday Session
13 Mar 24
Press releases
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
15 Mar 24
P3 Health Partners to Participate in the Jefferies Value Based Healthcare Summit
28 Feb 24
P3 Health Partners to Present at the TD Cowen 44th Annual Healthcare Conference
19 Feb 24
P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024
9 Jan 24
P3 Health Partners to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2 Jan 24